Solid Biosciences Inc
NASDAQ:SLDB

Watchlist Manager
Solid Biosciences Inc Logo
Solid Biosciences Inc
NASDAQ:SLDB
Watchlist
Price: 5.61 USD 6.25%
Market Cap: 437.1m USD

Net Margin
Solid Biosciences Inc

0%
Current
-256%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-167.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Solid Biosciences Inc
Glance View

Market Cap
436.9m USD
Industry
Biotechnology

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy (DMD). The company is headquartered in Cambridge, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2018-01-26. Duchenne is a genetic muscle-wasting disease predominantly affecting boys. SGT-001 and SGT-003 are its gene transfer candidates. SGT-001 and SGT-003 are designed to address the underlying genetic cause of Duchenne by delivering a synthetic transgene that produces dystrophin-like protein that is only expressed in muscles of the body, including cardiac and respiratory muscles. SGT-001 is its lead gene transfer candidate and utilizes an adeno-associated virus (AAV)9 vector. In addition to its gene transfer candidates, it has development programs focusing on platform technologies, including dual gene expression, a technology that allows it to package multiple transgenes into one vector, as well as capsids. The company is developing SGT-001 for the treatment of Duchenne through a single intravenous administration.

SLDB Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-167.1m
/
Revenue
0
What is the Net Margin of Solid Biosciences Inc?

Based on Solid Biosciences Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top